PRGO
HealthcarePerrigo Company plc
$14.17
+$0.28 (+2.02%)
Jan 5, 2026
Price History (1Y)
Analysis
Perrigo Company plc is a healthcare company operating in the drug manufacturers - specialty and generic industry. It has a market capitalization of $1.95B, annual revenue of $4.28B, and employs approximately 8,379 people. The company's financial health indicates negative net income of $-29,200,000, but positive EBITDA of $795.70M and free cash flow of $358.31M. Its gross margin is at 35.5%, operating margin at 9.0%, and profit margin at -1.2%. Return on equity (ROE) stands at -0.6% and return on assets (ROA) at 2.7%. Perrigo's balance sheet shows a debt-to-equity ratio of 86.82 and a current ratio of 2.51. Perrigo's valuation metrics include a forward P/E ratio of 5.08, EV/EBITDA of 6.71, price to book of 0.44, and price to sales of 0.46. Revenue growth is at -4.1% year-over-year. The company pays a dividend with an unusually high yield of 835.0%, supported by a payout ratio of 10950.0%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Perrigo Company plc
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Visit website →Key Statistics
- Market Cap
- $1.95B
- P/E Ratio
- N/A
- 52-Week High
- $30.93
- 52-Week Low
- $12.17
- Avg Volume
- 3.59M
- Beta
- 0.40
- Dividend Yield
- 835.00%
Company Info
- Exchange
- NYQ
- Country
- Ireland
- Employees
- 8,379